1. Аstakhova А.V., Lepakhin V.K. Lekarstva: neblagopriyantye pobochnye effekty i kontrol bezopasnosti. [Drugs: adverse reactions and safety control]. 2nd ed., Moscow, EKSMO Publ., 2008, 256 p.
2. Balasanyants G.S., Sukhinin D.S. Pobochnye deystviya protivotuberkuleznykh preparatov i metody ikh ustraneniya. [Side effects to anti-tuberculosis drugs and methods of their management]. 3rd ed., revised, St. Petersburg, 2014, pp. 64.
3. Gromova O.А., Torshin I.Yu., Egorova E.Yu. The molecular role of magnesium and pyridoxine in the anti-alcohol protection of the host. Vrach, 2010, no. 8, pp. 6-9. (In Russ.)
4. Ivanov D.A, Adverse reactions when managing tuberculosis patients. Tuberculosis and Lung Diseases, 2011, no. 6, pp. 60-69. (In Russ.)
5. Kompantseva E.V., Ovcharenko L.P., Khalata А.V., Kuleshova S.А., Blagorazumnaya N.V., Dukkardt L.N., Grakhantseva L.M. Pharmacokinetic and general toxic assessment of granules of isoniazid and pyridoxine hydrochloride. Ekologiya Cheloveka, 2007, no. 02, pp. 7-10. (In Russ.)